Patent · US Active

Polypeptides and methods for the specific detection of antibodies in patients with a Borrelia infection

US8163500B2 · kind B2 · utility

0Cited by

0References

13Claims

0Family size

Assignee

EUROIMMUN Medizinische Labordiagnostika AG · DE

Inventors

Lars Komorowski · Ratzeburg, DE
Christian Probst · Herrnburg, DE
Anthonina Janssen · Schiphorst, DE
Winfried Stöcker · Erkrath, DE

Key dates

Filing date	Dec 11, 2009
Grant date	Apr 24, 2012
Priority date	—
Expiry date	Dec 11, 2029

Classification

Technology area (CPC G)Physics
CPC primaryG01N2469/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to proteins derived from OspC from bacteria of the genus Borrelia, in particular a protein which comprises a first OspC polypeptide, wherein the first OspC polypeptide is linked to a second OspC polypeptide via a disulphide bridge. The disclosure also relates to a method for the detection of antibodies against OspC and a method for the detection of a Borrelia infection, wherein a protein according to the disclosure is employed, and also to a diagnostic kit and a vaccine against Borrelia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.